Retina Today
Retina Today is a privately held medical trade publication delivering peer-reviewed clinical content on retinal disease, surgery, and ophthalmic therapeutics to vitreoretinal specialists and fellows, monetized primarily through pharmaceutical and medical device advertising plus sponsored educational supplements.
- Company typePrivate
- Founded2006
- HeadquartersWayne, United States
- Headcount51–100
- GTM typeB2B
- OfferingDigital Commerce or Content
What Retina Today does
Retina Today is a privately held medical trade publication focused on the ophthalmology sub-specialty of retina, founded in 2006 and operated by Bryn Mawr Communications, LLC from Wayne, Pennsylvania. The publication delivers peer-reviewed clinical content, surgical technique guidance, and coverage of therapeutic developments in medical retina, retinal surgery, vitreous disease, diabetic retinopathy, retinal imaging, pediatric retina, posterior segment oncology, and ocular trauma to practicing vitreoretinal surgeons, medical retina specialists, uveitis experts, and retina fellows in training. Content is produced under Chief Medical Editors Allen C. Ho, MD and Robert L. Avery, MD, supported by an Editorial Advisory Board of prominent retina specialists and contributing authors from leading academic and clinical institutions.
The company's product portfolio is structured as an integrated media ecosystem rather than a single publication. The core Retina Today print and digital magazine is complemented by Eyetube (a video and podcast platform featuring New Retina Radio, Retinaws, Formula Retina 3D, and Clinical Minute Retina series), Eyewire+ (a retina industry news service), and YoungMD Connect (a networking and educational platform for retina trainees). The technology foundation is a content management system–driven website (retinatoday.com) with image delivery via CDN, alongside email newsletter distribution, social media presence across Facebook, Instagram, LinkedIn, and X/Twitter, and a robust print subscription logistics chain operated via ezsub.com. Additional offerings include a searchable article archive, a conference calendar covering AAO, ARVO, ASRS, ARDS, and Euretina, and sponsored editorial supplements on therapeutic pipeline topics.
Retina Today operates a freemium, two-sided media business model. Retinal specialists receive free print and email subscriptions, with global distribution channels for both print and digital content; the audience does not pay directly for content consumption. Revenue is generated primarily through advertising and sponsored educational supplements from pharmaceutical and medical device companies, with named advertiser relationships spanning Genentech, Astellas, Abbvie, Regenxbio, Allergan, and Zeiss. The company's broader footprint is defined by its parent, Bryn Mawr Communications, LLC, which also publishes Cataract & Refractive Surgery Today, Glaucoma Today, and Modern Optometry — establishing Retina Today as part of a multi-title ophthalmology media portfolio rather than a standalone enterprise. The company is independently owned with no recorded external investment, M&A activity, or public ownership.
Retina Today firmographics
Firmographics- Name
- Retina Today
- Legal name
- Bryn Mawr Communications, LLC
- Website
- https://retinatoday.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Retina Today is a privately held medical trade publication delivering peer-reviewed clinical content on retinal disease, surgery, and ophthalmic therapeutics to vitreoretinal specialists and fellows, monetized primarily through pharmaceutical and medical device advertising plus sponsored educational supplements.
- Ownership category
- akta.pro rank
Retina Today industry classification
Industry- Product category
- Ophthalmology Medical Publishing
- NAICS
- Newspaper, Periodical, Book, and Directory Publishers (5131)
- SIC
- Periodicals: Publishing Or Publishing & Printing (2721)
- akta.pro primary industry
- Retina & Vitreous Specialists (HLAKAKAE)
- akta.pro secondary industry
- Ophthalmology Specialty Pharmaceuticals (HLAIACAK)
Keywords
Where Retina Today is headquartered
LocationHeadquarters
- HQ city
- Wayne
- HQ country
- United States
- HQ region
- North America
Markets served
Retina Today business model
Business model- GTM type
- B2B
- Offering type
- Digital Commerce or Content
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Annual | Free subscription for print and email |
Distribution channels6 records
Marketing channels7 records
Retina Today product offering
Product offeringCore offering
Retina Today is a medical trade publication that delivers peer-reviewed clinical content on medical retina, retinal surgery, vitreous, diabetes, retinal imaging, pediatric retina, posterior segment oncology, and ocular trauma to practicing retina specialists. Content is distributed free of charge across print, website, email newsletter, podcast (New Retina Radio), and video (Eyetube) channels, with revenue generated through pharmaceutical-sponsored supplements and advertising from companies such as Genentech, Astellas, Abbvie, Regenxbio, Allergan, and Zeiss.
Product overview
Retina Today is a medical publication providing print and digital content covering research and clinical developments in medical retina, retinal surgery, vitreous, diabetes, retinal imaging, pediatric retina, posterior segment oncology, and ocular trauma. The portfolio includes the core Retina Today publication, the Eyetube video/podcast platform, the Eyewire+ news platform, and the YoungMD Connect community platform. Additional offerings include sponsored supplements on therapeutic topics, a conference calendar, and an article archive. Content is distributed through subscriptions, website access, and podcast/video streaming.
Differentiator
Problem solved
Functional benefit
Products and services
- Retina Today Publication Medical trade publication (print and digital) delivering peer-reviewed clinical content on medical retina, retinal surgery, vitreous, diabetes, retinal imaging, pediatric retina, posterior segment oncology, and ocular trauma, targeted at practicing vitreoretinal surgeons, medical retina specialists, and uveitis experts.
- Eyetube Video and podcast platform featuring retina-focused educational content including the New Retina Radio Journal Club, Retinaws, Formula Retina 3D, and Clinical Minute Retina series, with meeting coverage from AAO, ARVO, ASRS, and other major retina conferences.
- Eyewire+
- YoungMD Connect
- Retina Today Sponsored Supplements
Companies that use Retina Today
Customer profileSegments3 records
Ideal customer profiles2 records
Retina Today technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Retina Today partnerships and signals
Strategic signalRecent moves5 records
Expansion highlights5 records
Retina Today competitors and assessment
Company assessmentDirect peers
- Healio Ophthalmology: Digital specialty medical news and education platform serving ophthalmologists, including retina specialists. Comparable as a multi-format B2B medical media property with advertising, CME, and sponsored content offerings.
- Modern Optometry: Another Bryn Mawr Communications specialty publication, focused on optometrists. Comparable as a sibling B2B trade publication with the same freemium and advertising-supported model targeting eye-care professionals.
- Ophthalmology Times: Long-established trade publication covering ophthalmology, including retina topics. Directly comparable as a multi-platform B2B medical media property serving ophthalmologists and retina specialists with advertising and sponsored content.
- Ocular Surgery News: Trade news publication focused on ophthalmic surgery, including retina. Comparable as a digital-first B2B medical media outlet selling advertising and sponsored content to ophthalmologists and retina specialists.
- Review of Ophthalmology: Print and digital trade publication for ophthalmologists covering clinical and surgical retina. Directly comparable as a long-running niche B2B publication monetized through advertising and sponsored educational content.
- Retina Specialist: Trade publication dedicated to retina specialists. Directly comparable as a niche B2B publication targeting the same vitreoretinal specialist audience with advertising- and supplement-driven revenue.
- Glaucoma Today: Another Bryn Mawr Communications specialty publication serving ophthalmologists. Comparable as a sibling B2B trade publication with an identical advertising- and supplement-driven model, though focused on glaucoma rather than retina.
- Cataract & Refractive Surgery Today: Sister publication under Bryn Mawr Communications, LLC, covering cataract and refractive surgery. Directly comparable as a same-publisher B2B medical media brand with the same advertising/sponsored supplement model targeting ophthalmologists.
Broad incumbents
- American Society of Retina Specialists (ASRS): Professional society serving retina specialists with publications, meeting coverage, and educational content. Comparable as a content and meeting-coverage hub for the same audience, though not a commercial publisher.
- American Academy of Ophthalmology (AAO) Publications: AAO's EyeNet Magazine and broader publishing portfolio serve the entire ophthalmology profession, including retina specialists. Comparable as a major incumbent ophthalmology publisher with overlapping audience and advertiser relationships, but with society backing and broader scope.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Retina Today social profiles
Digital presenceRetina Today financial estimates
Financial estimateRevenue estimate
Valuation estimate
Retina Today leadership team
Management profileNumber of profiles
Retina Today funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Retina Today M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Retina Today
What does Retina Today do?
Retina Today is a medical trade publication that delivers peer-reviewed clinical content on medical retina, retinal surgery, vitreous, diabetes, retinal imaging, pediatric retina, posterior segment oncology, and ocular trauma to practicing retina specialists. Content is distributed free of charge across print, website, email newsletter, podcast (New Retina Radio), and video (Eyetube) channels, with revenue generated through pharmaceutical-sponsored supplements and advertising from companies such as Genentech, Astellas, Abbvie, Regenxbio, Allergan, and Zeiss.
Is Retina Today a public or private company?
Retina Today is a private company. It is classified as unknown and is currently operating.
When was Retina Today founded?
Retina Today was founded in 2006. It employs 51 to 100 people.
Where is Retina Today based?
Retina Today is headquartered in Wayne, United States, in the North America region.
Who are Retina Today's main competitors?
Direct peers on record are Healio Ophthalmology, Modern Optometry, Ophthalmology Times, Ocular Surgery News, Review of Ophthalmology, Retina Specialist, Glaucoma Today and Cataract & Refractive Surgery Today. Broad incumbents are American Society of Retina Specialists (ASRS) and American Academy of Ophthalmology (AAO) Publications.
Does Retina Today have an API?
No public API is recorded for Retina Today.
What industry is Retina Today in?
Retina Today's product category is Ophthalmology Medical Publishing. Its primary akta.pro industry code is HLAKAKAE, Retina & Vitreous Specialists, with a secondary code of HLAIACAK, Ophthalmology Specialty Pharmaceuticals. Its NAICS code is 5131 and its SIC code is 2721.